![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://ars.els-cdn.com/content/image/1-s2.0-S016041202100670X-ga1.jpg)
benzoapyrene phase 2 glutathione s transferase
benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and
Glutathione S transferases in kidney and urinary bladder tumors Nature Reviews Urology Benzo(a)pyrene and cardiovascular diseases: An overview of pre clinical studies focused on the underlying molecular mechanism Frontiers Benzo[a]pyreneEnvironmental Occurrence, Human Exposure, and Mechanisms of Toxicity PMC Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer Genes and Environment Springer Nature Link Metabolic pathway of BaP benzo[a]pyrene (BaP), benzo[a]pyrene 7, Download Scientific Diagram
USD23.72
USD47.72
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrurol.2009.49/MediaObjects/41585_2009_Article_BFnrurol200949_Fig1_HTML.jpg)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/978475/fnut-09-978475-HTML/image_m/fnut-09-978475-g001.jpg)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad6/9181839/ff47c629a5e7/ijms-23-06348-g006.jpg)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs41021-023-00278-1/MediaObjects/41021_2023_278_Fig2_HTML.png)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Glutathione S-transferases in kidney and](https://www.researchgate.net/publication/26332727/figure/fig3/AS:669332065513493@1536592608391/Metabolic-pathway-of-BaP-benzoapyrene-BaP-benzoapyrene-7.png)